Special Offer: Get 50% off your first 2 months when you do one of the following
Personalized offer codes will be given in each session
Attend a group training Schedule a 1-on-1 guided demo Watch a demo video

ABCD Webinar - Lipid update and cases

About This Webinar

Join us for our next webinar where we will be joined by TBC and TBC as they provide an update on lipid management, covering treatment targets, current guidelines, new lipid-lowering medicines, and the emerging role of Lp(a). These topics will be illustrated through a series of clinical cases, demonstrating how the latest evidence and recommendations can be applied in practice.

This webinar will help you understand:

- Review current lipid management guidelines and treatment targets for cardiovascular risk reduction.
- Understand the role of established and emerging lipid-lowering therapies, including new medicines and Lp(a) management.
- Apply the latest evidence and recommendations to clinical practice through illustrative patient cases.

Please note this webinar is intended for healthcare professionals only.

This webinar has been instigated and organised by ABCD. The support from our corporate sponsors has allowed us to provide this valuable educational meeting free of charge to all delegates. Sponsors have had no input into the agenda or the selection of speakers.

Please note: Certificates of attendance will be issued to those who attend the live webinar.

Who can view: Everyone
Webinar Price: Free
Featured Presenters
Webinar hosting presenter

Professor Jai Cegla

Consultant in Metabolic Medicine
Professor Jaimini Cegla is a consultant in Metabolic Medicine at Imperial College Healthcare NHS Trust. She has a specialist interest in lipidology and cardiovascular risk and splits her time between clinical, laboratory and academic research roles. In her clinical role she looks after the Hammersmith Hospital Lipid Service, a one-stop centre for the genetic diagnosis and management of lipid disorders, which also offers research facilities and access to new medications. Dr Cegla’s current research focuses on cardiovascular risk including clinical trials of novel therapeutic agents. Dr Cegla is a member of the Medical, Scientific and Research Committee of HEART UK, the cholesterol charity. She also sits on the National Clinical Advisory Group for Lipids, that advises NHS England for strategy on CVD prevention.
VIEW PROFILE
Webinar hosting presenter

Professor Dev Datta

Consultant in Metabolic Medicine
Dev Datta MB BCh MD FRCP FRCPath
Consultant in Metabolic Medicine, Cardiff, UK
Visiting Professor, University of South Wales

After completing medical school in Cardiff, Dev trained in cardiology and general medicine in Wales and Edinburgh. He was awarded a BHF junior research fellowship at Cardiff University and was subsequently awarded his MD. Having developed an interest in preventative cardiology and vascular medicine, he then completed training in medical biochemistry and metabolic medicine in Cardiff and was appointed as a consultant in 2011.

He is clinical lead for the lipoprotein apheresis service in Cardiff and is medical lead for the Welsh Familial Hypercholesterolaemia cascade testing service. He is clinical lead for the specialist weight management service in Cardiff and Clinical Director for Metabolic Medicine. He is a trustee of HEART UK and vice-chair of the HEART UK Medical, Scientific & Research Committee. He is course director for the MSc in Preventative Cardiovascular Medicine at University of South Wales.
VIEW PROFILE
Webinar hosting presenter

Dr Davide Iacuaniello

Consultant in Endocrinology and Diabetes
Dr Davide Iacuaniello is a Consultant in Endocrinology and Diabetes at Lister Hospital. His specialist interests in diabetes include cardio-renal-metabolic medicine and diabetes technology. He established and leads a multidisciplinary diabetes–kidney clinic (MDT) and a cardio-lipid service. He also has a subspecialty interest in endocrine disorders, with a particular focus on pituitary and adrenal diseases. He has authored peer-reviewed publications in this field and is currently the Principal Investigator for clinical trials. In September 2025, he was appointed Audit Lead for the ABCD Audit Programme.
VIEW PROFILE
Recommended
Powered by BigMarker